Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022

Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022

Given its enhanced genetic stability, novel oral poliovirus vaccine type 2 was deployed for type 2 poliovirus outbreak responses under World Health Organization Emergency Use Listing. We evaluated the safety profile of this vaccine. No safety signals were identified using a multipronged approach of...

Full description

Bibliographic Details
Main Authors: Farrell A. Tobolowsky, Fred Nsubuga, Zunera Gilani, Annet Kisakye, Helen Ndagije, Daniel Kyabayinze, Jane F. Gidudu
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2024-04-01
Series:Emerging Infectious Diseases
Subjects:
viruses
poliovirus
vaccines
vaccine safety
Uganda
Online Access:https://wwwnc.cdc.gov/eid/article/30/4/23-1361_article

Similar Items

Similar Items